‘I have no money’: Thousands of Americans see their savings vanish in Synapse fintech crisis

‘I have no money’: Thousands of Americans see their savings vanish in Synapse fintech crisis


Key Points
  • Thousands of Americans will receive little or nothing from savings accounts that were locked during the collapse of fintech middleman Synapse.
  • Customers believed the accounts were backed by the full faith and credit of the U.S. government.
  • CNBC spoke to a dozen customers caught in the predicament, people who have lost sums ranging from $7,000 to well over $200,000.
  • While there’s not yet a full tally of those left shortchanged, at fintech Yotta alone, 13,725 customers say they are being offered a combined $11.8 million despite putting in $64.9 million in deposits.



Source

Here are 3 forces that drove the stock market during Wall Street’s comeback week
Finance

Here are 3 forces that drove the stock market during Wall Street’s comeback week

The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names like Meta Platforms , Nvidia and Amazon . The tech-heavy index ended the week 1.9% […]

Read More
Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’
Finance

Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’

ETF Edge Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’ Published Sat, Feb 21 202611:00 AM EST Blair Bao WATCH LIVE Source

Read More
Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more
Finance

Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more

Check out the companies making headlines before the bell. Grail — Shares cratered 47% after the company said a trial of one of its drugs missed its primary endpoint and failed to show statistically significant Stage III-IV cancer reduction. Blue Owl Capital — Shares slid nearly 3%, a day after after the private market and […]

Read More